Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world study of tenofovir disoproxil fumarate in chronic hepatitis B
ChiCTR1800019508Phase 4Not yet recruiting
- Sponsor
- Beijing YouAn Hospital
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of tenofovir disoproxil fumarate in Chronic Hepatitis B (CHB), sponsored by Beijing YouAn Hospital. Primary endpoints: Liver function, Kidney function and 14 more. Planned start Dec 2018; status: not yet recruiting.
02
Drugs
tenofovir disoproxil fumarate
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR1800019508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800019508.